Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer

Els Berns; Jan Klijn; Maxime Look; N Grebenchtchikov; R Vossen; HAAM (Harry) Peters; A Geurts-Moespot; H (Henk) Portengen; I Staveren; M Meijer - Gelder; B Bakker; FCGJ Sweep; John Foekens

Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer

Els Berns
, Jan Klijn
, Maxime Look
, N Grebenchtchikov
, R Vossen
, HAAM (Harry) Peters
, A Geurts-Moespot
, H (Henk) Portengen
, I Staveren
, M Meijer - Gelder
, B Bakker
, FCGJ Sweep
, John Foekens

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

68 Citations (Scopus)

9 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	1253-1258
Number of pages	6
Journal	Clinical Cancer Research
Volume	9
Publication status	Published - 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-03-86-01

Access to Document

12684392.pdfFinal published version, 51.5 KB

http://hdl.handle.net/1765/10121

Cite this

Berns, E., Klijn, J., Look, M., Grebenchtchikov, N., Vossen, R., Peters, HAAM., Geurts-Moespot, A., Portengen, H., Staveren, I., Meijer - Gelder, M., Bakker, B., Sweep, FCGJ., & Foekens, J. (2003). Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer. Clinical Cancer Research, 9, 1253-1258. http://hdl.handle.net/1765/10121

@article{c06ffa1e99ca4084af385fc480dc65ae,

title = "Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer",

author = "Els Berns and Jan Klijn and Maxime Look and N Grebenchtchikov and R Vossen and Peters, \{HAAM (Harry)\} and A Geurts-Moespot and Portengen, \{H (Henk)\} and I Staveren and \{Meijer - Gelder\}, M and B Bakker and FCGJ Sweep and John Foekens",

year = "2003",

language = "Undefined/Unknown",

volume = "9",

pages = "1253--1258",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

}

Berns, E, Klijn, J, Look, M, Grebenchtchikov, N, Vossen, R, Peters, HAAM, Geurts-Moespot, A, Portengen, H, Staveren, I, Meijer - Gelder, M, Bakker, B, Sweep, FCGJ & Foekens, J 2003, 'Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer', Clinical Cancer Research, vol. 9, pp. 1253-1258. <http://hdl.handle.net/1765/10121>

TY - JOUR

T1 - Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer

AU - Berns, Els

AU - Klijn, Jan

AU - Look, Maxime

AU - Grebenchtchikov, N

AU - Vossen, R

AU - Peters, HAAM (Harry)

AU - Geurts-Moespot, A

AU - Portengen, H (Henk)

AU - Staveren, I

AU - Meijer - Gelder, M

AU - Bakker, B

AU - Sweep, FCGJ

AU - Foekens, John

PY - 2003

Y1 - 2003

M3 - Article

SN - 1078-0432

VL - 9

SP - 1253

EP - 1258

JO - Clinical Cancer Research

JF - Clinical Cancer Research

ER -